Catalyst Wire Dossier Catalyst Wire Dossier

NGA-01 Gel

· Nutrin GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NGA-01 Gel, covering 2022-01-31 to 2022-01-31. Get the full timeline:

Most recent: Clinical Trial Update: NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain [Phase 2, Phase 3]

See pricing